Discover 1,077 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,077
Active & ResponsiveNew
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
for
Acute Biphenotypic Leukemia, Acute Leukemia,
Location: Portland OR, Seattle WA, Los Angeles CA, Iowa City IA,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 0 - 26
Code: NCT03779854
Phase2, Recruiting
Active & Responsive
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Portland OR, Vancouver, Clovis CA, Edmonton,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Portland OR, Vancouver WA, Vancouver, Kelowna,
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: Portland OR, Bellevue WA, Kelowna, Sherman Oaks CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Portland OR, Chicago IL, Nashville TN, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
for
Primary Central Nervous System Lymphoma
Location: Portland OR, Seattle WA, Charlottesville VA, Hershey PA,
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06175000
Phase2, Recruiting
Active & Responsive
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease